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A B S T R A C T
Elevated plasma Lp(a) has been linked to development of coronary artery disease
(CAD). There is no data about plasma Lp(a) and atherosclerosis of the retinal arteries.
Therefore the purpose of this study was to assess the risk of retinal vessels atherosclero-
sis conferred by elevated plasma Lp(a) levels in 73 adult males. The results were com-
pared with those in 45 matched apparently healthy males with no retinal vessel
changes. The atherosclerotic changes of the retinal vessels were determined by direct
ophthalmoscopy and graded (1–4) according to Scheie. Plasma levels of Lp(a) were mea-
sured by radial immunodiffusion. The results were compared using chi-square test. Al-
though a very weak correlation between plasma Lp(a) levels and the incidence of retinal
atherosclerosis was found, no significant association between the degree of atheroscle-
rotic changes and plasma Lp(a) levels could be proven. Thus it could be concluded that
plasma Lp(a) level is not a significant risk factor for atherosclerosis of the retinal
arteries.
Introduction
An increasing number of studies sug-
gests that lipoprotein(a) /Lp(a)/ might be
an independent, discriminating risk fac-
tor for atherosclerotic disease in men1,2.
This seems to be true not only for coro-
nary artery disease (CAD) and myocar-
dial infarction3–5 but also atherosclerosis
of carotid arteries and ischemic stroke6,7
as well as atherosclerosis of peripheral
arteries, particularly of lower extremities7,8.
Lp(a) is a plasma lipoprotein whose con-
centration is stable and genetically deter-
mined in an individual and whose compo-
sition closely resembles that of atherogenic
LDL, but with one additional molecule of
apoprotein(a) /apo(a)/10. Apo(a) is a large
glycoprotein linked to apoprotein B
(apoB) by a disulfide bond and structur-
ally similar to plasminogen. It has been
postulated that this similarity is one of
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the mechanisms by which Lp(a) promotes
atherosclerosis11. Namely, Lp(a) com-
petes with plasminogen for binding to fi-
brin and to plasminogen receptors on the
vascular endothelium surface thus inter-
fering with fibrinolysis and accelerating
atherothrombosis. Lp(a) also increases
the activity of plasminogen activator in-
hibitor-1 (PAI-1)12 and reduces the activ-
ity of transforming growth factor-beta
(TGF-beta) resulting in inhibition of fibri-
nolysis and promotion of migration and
proliferation of smooth muscle cells
(SMC)13. It is well known that SMC mi-
gration and proliferation is an important
feature of atherogenesis14. Lp(a) also
binds to elastin via apo B, resulting in ox-
idation and oxidatively modified Lp(a) in
a fashion similar to LDL, and such Lp(a)
is then taken up by macrophages13,15.This
process promotes the transformation of
macrophages into foam cells which is an
important step in early atherogenesis.
There is currently no information on the
effectiveness on either dietary or drug
treatment which could decrease Lp(a)
plasma concentration apart from obser-
vation that hormone replacement thera-
py16,17 and antiestrogen tamoxifen18 could
do it.
Although atherosclerotic changes have
been described in the retinal arteries half
a century ago, there is no data in the lit-
erature about Lp(a) and retinal artery
atherosclerosis. Therefore, the aim of this
study was to assess whether any associa-
tion exists between Lp(a) and atheroscle-
rosis of retinal arteries in adult men.
Material and Methods
Subjects
The study group consisted of 73 males
with atherosclerotic changes of retinal ar-
teries and an age, smoking and BMI
matched control group of 45 males with
normal eye fundus. Neither of the sub-
jects was acutely ill nor was receiving any
lipid lowering agents, antihypertensives,
steroids, or any other drugs known to in-
fluence plasma lipids at the time of the
study and over the 3 months prior to the
study. Exclusion criteria were: diabetes
or impaired glucose tolerance, hyperten-
sion (BP higher than 140/90 mmHg), clin-
ical hypo- or hyperthyreosis, clinical
adrenocortical hyperfunction or insuffi-
ciency, clinical liver disease, clinical renal
disease, chronic or acute pancreatitis, for-
mer or present malignant disease, auto-
immune diseases, extreme obesity (BMI
>35), a history of drug abuse and/or a his-
tory of alcohol consumption greater than
21 units per week, as well as a history of
myocardial infarction, angioplasty, stro-
ke, or major surgery during the 6 months
preceding the study.
The study complied with the Declara-
tion of Helsinki. All subjects received oral
and written information concerning the
study prior to giving written informed
consent.
Analysis of the retinal arteries
In all the subjects the eye fundus ex-
amination was carried out by direct
ophthalmoscopy performed after the pu-
pil dilatation by the same ophthalmolo-
gist. The atherosclerotic vascular lesions
in the retinal arteries were classified ac-
cording to Scheie19,20. Namely, Scheie de-
veloped a four-scale classification of athe-
rosclerotic changes of retinal arteries
which was used in this study:
Stage 1 – A broadening of the light re-
flex from the artery can be seen, with
minimal or no arteriovenous compres-
sion. This is the earliest sign of retinal ar-
tery atherosclerosis.
Stage 2 – The changes are similar to
those in Stage 1 but more prominent.
Stage 3 – The arteries have a »copper
wire« appearance and there is much more
arteriovenous compression. These are se-
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rious atherosclerotic changes of retinal
arteries.
Stage 4 – The arteries have a »silver
wire« appearance and the arteriovenous
crossing changes are most severe. This is
the most severe form of the atherosclero-
sis of the retinal arteries.
Measurement of plasma Lp(a)
All samples were collected between 8
and 9 am, after a 12–14 h overnight fast,
and after 15 min of rest in supine posi-
tion. Cubital venous blood was drawn
into evacuated blood-collection tubes
without anticoagulant. After clotting, each
specimen was centrifuged at 1200 x g for
20 min at –4°C, immediately frozen and
stored at –20°C for a maximum of one
week. The plasma concentration of Lp(a)
was measured by radial immunodif-
fusion21 using the antisera from Immuno
AG, Austria. Lp(a) was considered ele-
vated if the concentration was higher
that 0.3 g/L.
Statistical analysis
Plasma Lp(a) concentrations for pa-
tients with retinal artery atherosclerosis
and subjects with no retinal artery chan-
ges were compared by using chi – square
test. Statistical significance was assumed
for p less than 5% (p < 0.05).
Results
Patients with the atherosclerosis of
retinal arteries were 48.23 +/– 9.71 years
old (range 25 – 69 years) and had a BMI
24.2 +/–2.4. Controls were 47.60 +/–9.22
years old (range 22 – 65 years) and had a
BMI 24.1 +/– 2.0.
A very weak correlation between plas-
ma Lp(a) levels and retinal vessels ath-
erosclerosis was found (c2 = 4.51008; df =
1; p < 0.05). However, no significant asso-
ciation between the degree of atheroscle-
rotic changes of retinal arteries and plas-
ma Lp(a) concentration could be proved
(Table 1).
Discussion
To our knowledge, this is the first re-
port of a study investigating the relation-
ship between Lp(a) and retinal artery
atherosclerosis. Almost four decades ago
it was noticed that 73% of patients with
atherosclerotic retinal changes have
atherosclerotic changes of other arteries
as well, while 72% of the patients who
had atherosclerosis of the arteries in
some other part of the body had also athe-
rosclerotic changes of the retinal arte-
ries22–24. However, these investigators did
not check Lp(a) in their patients.
Atherosclerotic changes of the retinal
arteries are characterized by the thicken-
ing of the arterial wall and lipid deposi-
tion in the intima often associated with fi-
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TABLE 1
THE STAGE OF THE ATHEROSCLEROTIC
CHANGES OF THE RETINAL ARTERIES
AND PLASMA LP(A) CONCENTRATION
Lipoprotein(a) (g/l)




















































a = number of subjects; b = % horizontal;
c = % vertical;  2 = 5.79935, df = 4, p > 0.1
brosis and even calcification of larger
arteries. Sometimes in the literature the
retinal arteries are called arterioles19 but
the arteries that are analyzed by ophthal-
moscopy (branches of the central retinal
artery) do have all the layers (intima, me-
dia, adventitia) and resemble all the small
arteries in other organs including heart
and brain25. Arterioles with the diameter
smaller than 63 and 134 micrones26 lack
an internal elastic lamina, and a con-
tinuos layer of smooth muscle cells but they
and the capillary vessels were not ana-
lyzed by ophthalmoscopy in this study27.
We have recently shown that athero-
sclerosis of the retinal vessels strongly
correlates with plasma total cholesterol,
LDL-cholesterol, triglycerides and apo-
protein B levels which corresponds to the
findings in CAD and ischemic stroke28.
Therefore our results presented in this
paper showing no correlation between
plasma Lp(a) levels and retinal artery
atherosclerosis were quite surprising.
However, despite the reports indicat-
ing that increased plasma Lp(a) is a risk
factor for restenosis after balloon coro-
nary angioplasty29 and coronary by pass
surgery30 as well as several studies pub-
lished in the last 20 years starting from the
first one by Kostner et al31 suggesting an
association between Lp(a) and CAD5,32–34,
there were opposing reports too. Several
studies showed that plasma Lp(a) was
not a predictor of future coronary
events35–38 thus questioning the previ-
ously presented hypothesis. Our results
are congruent with the results of these
studies suggesting that clinical signifi-
cance of increased Lp(a) concentration as
a risk factor for atherosclerosis is ques-
tionable, at least for retinal artery ath-
erosclerosis.
Although there was no previous study
about Lp(a) and atherosclerosis of the
retinal arteries, several studies have
found an association between increased
Lp(a) and central or branch retinal artery
occlusion39–42.
There is no readily apparent source of
bias to explain the discrepancy between
the findings of our study which demon-
strated a lack of association between
Lp(a) and the risk of retinal artery ath-
erosclerosis as well as other studies
showing similar data for Lp(a) and CAD
and studies which have found a link be-
tween elevated Lp(a) levels and the risk
for CAD or retinal vascular occlusion.
The results from any one study should be
considered in the context of all other in-
formation. Thus our results do not negate
the role of Lp(a) in atherogenesis in gen-
eral and in all types of the arteries but
further prospective studies are needed to
explain whether susceptibility to athero-
sclerotic damage of the vascular walls
and the role of Lp(a) in it is synchronous
and uniform in different organs.
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JE LI LIPOPROTEIN(A) ^IMBENIK RIZIKA ZA ATEROSKLEROZU
ARTERIJA MRE@NICE?
S A @ E T A K
Pove}ana koncentracija Lp(a) u plazmi povezuje se s aterosklerozom koronarnih ar-
terija srca. Me|utim, nema nikakvih podataka o Lp(a) i aterosklerozi mre`ni~nih arte-
rija. Stoga je cilj ovog istra`ivanja bio ustanoviti da li pove}ana koncentracija Lp(a) u
plazmi predstavlja ~imbenik rizika za aterosklerozu arterija mre`nice. U ispitivanje su
uklju~ena 73 odrasla mu{karca s aterosklerozom arterija mre`nice, a rezultati su us-
pore|eni s onima u 45 zdravih mu{karaca podjednake dobi, uhranjenosti i ostalih
obilje`ja koji nisu imali nikakvih promjena na arterijama mre`nice. Ateroskleroti~ke
promjene arterija mre`nice procjenjivane su uz pomo} direktne oftalmoskopije i stup-
njevane su od 1 do 4 prema Scheieu. Koncentracije Lp(a) u plazmi odre|ivane su ra-
dijalnom imunodifuzijom. Rezultati su uspore|eni hi-kvadrat testom. Iako je uo~ena
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vrlo slaba povezanost izme|u koncentracije Lp(a) i pojave ateroskleroze arterija mre-
`nice, nije se uspjela dokazati povezanost izme|u stupnja ateroskleroti~kih promjena
mre`ni~nih arterija i koncentracije Lp(a). Stoga autori zaklju~uju da pove}ani Lp(a)
nije zna~ajan ~imbenik rizika za aterosklerozu mre`ni~nih arterija.
